Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reduced-dose Radiotherapy Following High-dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Central Nervous System Non-germinomatous Germ Cell Tumors

NCT02784054 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT02784054
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02784054 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reduced-dose Radiotherapy Following High-dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Central Nervous System Non-germinomatous Germ Cell Tumors
Lead sponsor
Samsung Medical Center
Phase
Phase 2
Overall status
Unknown status
Start date
April 30, 2014
Completion date
March 31, 2023
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intracranial non-germinomatous germ cell tumor